Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
5 mg | In stock | $ 77.00 | |
10 mg | In stock | $ 108.00 | |
25 mg | In stock | $ 179.00 | |
50 mg | In stock | $ 266.00 | |
100 mg | In stock | $ 395.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 90.00 |
Description | Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines. |
Source |
Synonyms | Rutundic acid |
Molecular Weight | 488.7 |
Formula | C30H48O5 |
CAS No. | 20137-37-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200.5 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rotundic acid 20137-37-5 Apoptosis Cytoskeletal Signaling MAPK Others PI3K/Akt/mTOR signaling p38 MAPK Akt mTOR Mammalian target of Rapamycin Rutundic acid Protein kinase B PKB Inhibitor inhibit inhibitor